[ASTRO] QoQ Quarter Result on 31-Jul-2013 [#2]

Stock
[ASTRO] ASTRO MALAYSIA HOLDINGS BERHAD
Announcement Date
11-Sep-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2014
Quarter
31-Jul-2013 [#2]
Profit Trend
QoQ- -13.41%
YoY- 4.62%
Quarter Report
Latest QR
Upcoming QR
ASTRO's Result
ASTRO's Financial Summary
View:
Show?
Quarter Result
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
Revenue 1,253,855 1,260,150 1,216,515 1,188,279 1,125,798 1,131,590 1,078,441 10.59%
PBT 168,284 127,160 152,693 131,546 157,831 114,720 158,451 4.10%
Tax -39,287 -15,293 -29,135 -33,018 -44,022 -31,369 -40,496 -2.00%
NP 128,997 111,867 123,558 98,528 113,809 83,351 117,955 6.16%
-
NP to SH 128,332 111,386 123,712 98,833 114,136 83,158 118,088 5.71%
-
Tax Rate 23.35% 12.03% 19.08% 25.10% 27.89% 27.34% 25.56% -
Total Cost 1,124,858 1,148,283 1,092,957 1,089,751 1,011,989 1,048,239 960,486 11.13%
-
Net Worth 618,279 629,584 519,590 551,904 526,063 511,941 196,434 115.22%
Dividend
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
Div 116,901 159,120 103,093 104,034 103,759 129,934 34,063 128.03%
Div Payout % 91.09% 142.85% 83.33% 105.26% 90.91% 156.25% 28.85% -
Equity
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
Net Worth 618,279 629,584 519,590 551,904 526,063 511,941 196,434 115.22%
NOSH 5,195,627 5,304,000 5,154,666 5,201,736 5,187,999 5,197,374 2,270,923 73.89%
Ratio Analysis
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
NP Margin 10.29% 8.88% 10.16% 8.29% 10.11% 7.37% 10.94% -
ROE 20.76% 17.69% 23.81% 17.91% 21.70% 16.24% 60.12% -
Per Share
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
RPS 24.13 23.76 23.60 22.84 21.70 21.77 47.49 -36.40%
EPS 2.47 2.14 2.40 1.90 2.20 1.60 5.20 -39.20%
DPS 2.25 3.00 2.00 2.00 2.00 2.50 1.50 31.13%
NAPS 0.119 0.1187 0.1008 0.1061 0.1014 0.0985 0.0865 23.76%
Adjusted Per Share Value based on latest NOSH - 5,201,736
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
RPS 24.02 24.15 23.31 22.77 21.57 21.68 20.66 10.59%
EPS 2.46 2.13 2.37 1.89 2.19 1.59 2.26 5.83%
DPS 2.24 3.05 1.98 1.99 1.99 2.49 0.65 128.66%
NAPS 0.1185 0.1206 0.0996 0.1057 0.1008 0.0981 0.0376 115.41%
Price Multiplier on Financial Quarter End Date
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
Date 30/04/14 30/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 -
Price 3.33 2.94 2.90 3.00 2.95 2.79 2.71 -
P/RPS 13.80 12.37 12.29 13.13 13.59 12.81 5.71 80.38%
P/EPS 134.82 140.00 120.83 157.89 134.09 174.37 52.12 88.76%
EY 0.74 0.71 0.83 0.63 0.75 0.57 1.92 -47.13%
DY 0.68 1.02 0.69 0.67 0.68 0.90 0.55 15.23%
P/NAPS 27.98 24.77 28.77 28.28 29.09 28.32 31.33 -7.28%
Price Multiplier on Announcement Date
30/04/14 31/01/14 31/10/13 31/07/13 30/04/13 31/01/13 31/10/12 CAGR
Date 18/06/14 31/03/14 05/12/13 11/09/13 12/06/13 14/03/13 05/12/12 -
Price 3.54 3.20 2.85 2.96 3.03 2.76 2.97 -
P/RPS 14.67 13.47 12.08 12.96 13.96 12.68 6.25 76.89%
P/EPS 143.32 152.38 118.75 155.79 137.73 172.50 57.12 84.95%
EY 0.70 0.66 0.84 0.64 0.73 0.58 1.75 -45.80%
DY 0.64 0.94 0.70 0.68 0.66 0.91 0.51 16.39%
P/NAPS 29.75 26.96 28.27 27.90 29.88 28.02 34.34 -9.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment